Veterinary Medicines

OXYTOCIN/ΑNAFASIS 10IU/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ

Authorised
  • OXYTOCIN SYNTHETIC
Download as PDF

Product identification

Medicine name:
OXYTOCIN/ΑNAFASIS 10IU/ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
  • OXYTOCIN SYNTHETIC
Target species:
  • Horse (mare)
  • Cattle (cow)
  • Sheep (ewe)
  • Goat
  • Pig (sow)
  • Dog (bitch)
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • OXYTOCIN SYNTHETIC
    10.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Horse (mare)
      • Not applicable
        no withdrawal period
    • Cattle (cow)
      • Not applicable
        no withdrawal period
    • Sheep (ewe)
      • Not applicable
        no withdrawal period
    • Goat
      • Not applicable
        no withdrawal period
    • Pig (sow)
      • Not applicable
        no withdrawal period
    • Dog (bitch)
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH01BB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Uplab Pharmaceutical Company Ltd.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 99755/22-10-2021/K-0210501
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."